Andrew Thomas Crockett - CEO, Kalvista Pharmaceuticals, Inc

As of May 19, 2022


What is Andrew Thomas Crockett's Net Worth?

The current estimated net worth of Kalvista Pharmaceuticals, Inc's CEO, Andrew Thomas Crockett, is estimated to be about $5.37M . Andrew Thomas Crockett owns about 114,670 units of Kalvista Pharmaceuticals, Inc common stock. In the last 5 years at Kalvista Pharmaceuticals, Inc, Andrew Thomas Crockett has sold an estimated value of $3.27M worth.

What is Andrew Thomas Crockett's Past Insider Trading?

Andrew Thomas Crockett's largest sale order was 38,539 units , worth over $693.03K on October 22, 2020. In total, Andrew Thomas Crockett has made about 25 transactions over 5 years of their time at Kalvista Pharmaceuticals, Inc. Andrew Thomas Crockett usually trades in May, with the busiest year in 2021. The most recent transaction was a sale order of 10,000 units , worth over $170.69K on March 11, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Andrew Thomas Crockett's Salary in 2021?

As CEO of Kalvista Pharmaceuticals, Inc, Andrew Thomas Crockett has a total base salary of $556,120 . Andrew Thomas Crockett received compensation valued at about $2,308,027 in 2021 after becoming CEO. The vast majority of their compensation came in the form of a bonus of $458,799 , option awards of $1,281,708 , and other compensation of $11,400 .

What is Andrew Thomas Crockett's' Mailing Address?

  • Mailing address is Building 227, Tetricus Science Park Porton Down, Salisbury Wiltshire X0 SP4 0JQ United Kingdom

Kalvista Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
T. Andrew Crockett 2021 $556,120 $458,799 - $1,281,708 $11,400 $2,308,027
T. Andrew Crockett 2020 $556,120 $229,400 - $1,163,160 $11,882 $1,960,562
T. Andrew Crockett 2019 $505,000 $353,500 - $2,418,444 $11,000 $3,287,944
Benjamin L. Palleiko 2021 $435,000 $261,000 - $747,663 $15,850 $1,459,513
Benjamin L. Palleiko 2020 $435,000 $156,600 - $581,580 $11,900 $1,185,080
Benjamin L. Palleiko 2019 $366,000 $192,150 $527,794 $994,555 $11,000 $2,091,499
Christopher M. Yea 2021 $420,000 $252,000 - $712,060 $25,341 $1,409,401
Christopher M. Yea 2020 $420,000 $117,600 - $480,773 $25,271 $1,094,044
Christopher M. Yea 2019 $341,093 $174,596 - $891,350 $20,466 $1,427,505
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1348911/000119312521249158/d191826ddef14a.htm

What are Kalvista Pharmaceuticals, Inc's Past Insider Trades?

Kalvista Pharmaceuticals, Inc's most recent insider trade came on March 11, 2022 by Andrew Thomas Crockett who sold 10,000 units worth $170.69K . In the last 5 years, insiders at Kalvista Pharmaceuticals, Inc have sold an estimated value of $75.53M and bought an estimated value of $44.2M worth of shares. Insider trading is most common in October, with the busiest year in 2019 and 2021. The most active traders at the company are Andrew Thomas Crockett, CEO,  Christopher Yea, Chief Development Officer,  and Edward Feener, Chief Scientific Officer .

KalVista Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1